Market Overview:
The global enzymatic debridement agents for wound market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic wounds, rising geriatric population, and technological advancements in wound care products. The global enzymatic debridement agents for wound market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into collagenase product, papain product, and others. The collagenase product segment is expected to dominate the global enzymatic debridement agents for wound market during the forecast period owing to its ability to effectively remove necrotic tissue from wounds without causing any damage to healthy tissues surrounding it. On the basis of application, hospitals are expected to account for a major share ofthe global enzymatic debridement agents for woundmarket duringthe forecast period owingto their large patient base and growing demandfor advancedwound care products.
Product Definition:
Enzymatic debridement agents are used to remove dead or damaged tissue from a wound. This can help promote healing and prevent infection.
Collagenase Product:
Collagenase is a proteolytic enzyme that is produced by the skin and bone marrow of animals and humans. It has been used in various applications such as food, cosmetics, pharmaceuticals, research & development activities for wound debridement and treatment of certain diseases.
Papain Product:
Papain is a proteolytic enzyme that is obtained from the Papaya plant. It has been used in wound debridement and treatment of exudative wounds for thousands of years. The use of papain-based products as an enzymatic debridement agent was first reported in 1881, wherein it was used to treat leg ulcers.
Application Insights:
Based on the application, the global enzymatic debridement agents for wound market is segmented into hospitals, clinics and others. Hospitals held the largest share of over 70% in 2017 owing to rising cases of burn injuries and trauma across the globe. Rising awareness about these products among healthcare professionals coupled with increasing government funding for hospital care has led to a large share of this segment.
Clinics are expected to witness significant growth over the forecast period due to an increase in lifestyle-related disorders such as obesity and diabetes which may result in lower immunity against infections that may require surgical procedures at a later stage. Rising demand for minimally invasive surgeries is also anticipated fuel product demand during this period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of developed healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending levels in this region. In addition, increasing sports injuries and road accidents are also driving the demand for enzymatic debridement agents in North America.
Asia Pacific is expected to witness lucrative growth over the forecast period due to factors such as rising population, improving economic conditions and growing medical tourism industry especially pertaining to countries such as India, China and Japan. Moreover, a large number of pharmaceutical companies are investing huge amounts in research & development activities which will drive product adoption over next eight years.
Growth Factors:
- Increasing incidence of chronic wounds: The increasing incidence of chronic wounds is one of the key growth drivers for the enzymatic debridement agents for wound market. According to a study by the National Institute of Health, around 6.5 million people in the U.S are affected by chronic wounds every year, which is likely to increase in future due to rising geriatric population and prevalence of lifestyle-associated diseases such as obesity and diabetes. This is expected to create significant demand for enzymatic debridement agents over the next few years.
- Growing awareness about benefits of enzymatic debridement: There is growing awareness among healthcare professionals and patients about the benefits of enzymatic debridement over traditional methods such as sharp or surgical debridement. This is helping to drive demand for these agents, thereby fuelling market growth.
- Technological advancements: The advent of new technologies has led to development of novel enzymes that are more effective in removing necrotic tissue from wounds than older generation enzymes used in currently available products In addition, introductionof advanced delivery systems that improve ease-of-use and patient compliance are also aiding market growth .
- accordingto a United Nations Population Fund (UNFPA) study .This will lead tobigger numbers offoreignpatients seeking
Scope Of The Report
Report Attributes
Report Details
Report Title
Enzymatic Debridement Agents for Wound Market Research Report
By Type
Collagenase Product, Papain Product, Others
By Application
Hospitals, Clinics, Others
By Companies
Smith & Nephew, Stratus Pharma, WeiBang Biopharm, MediWound, Virchow
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Enzymatic Debridement Agents for Wound Market Report Segments:
The global Enzymatic Debridement Agents for Wound market is segmented on the basis of:
Types
Collagenase Product, Papain Product, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Smith & Nephew
- Stratus Pharma
- WeiBang Biopharm
- MediWound
- Virchow
Highlights of The Enzymatic Debridement Agents for Wound Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Collagenase Product
- Papain Product
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enzymatic Debridement Agents for Wound Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Enzymatic debridement agents are medications that help to clean and remove dead tissue from wounds. This can help to improve the healing process and reduce the risk of infection.
Some of the major players in the enzymatic debridement agents for wound market are Smith & Nephew, Stratus Pharma, WeiBang Biopharm, MediWound, Virchow.
The enzymatic debridement agents for wound market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Enzymatic Debridement Agents for Wound Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Enzymatic Debridement Agents for Wound Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Enzymatic Debridement Agents for Wound Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Enzymatic Debridement Agents for Wound Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Enzymatic Debridement Agents for Wound Market Size & Forecast, 2020-2028
4.5.1 Enzymatic Debridement Agents for Wound Market Size and Y-o-Y Growth
4.5.2 Enzymatic Debridement Agents for Wound Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Collagenase Product
5.2.2 Papain Product
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Enzymatic Debridement Agents for Wound Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Enzymatic Debridement Agents for Wound Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Collagenase Product
9.6.2 Papain Product
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Collagenase Product
10.6.2 Papain Product
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Collagenase Product
11.6.2 Papain Product
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Collagenase Product
12.6.2 Papain Product
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Collagenase Product
13.6.2 Papain Product
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Enzymatic Debridement Agents for Wound Market: Competitive Dashboard
14.2 Global Enzymatic Debridement Agents for Wound Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Smith & Nephew
14.3.2 Stratus Pharma
14.3.3 WeiBang Biopharm
14.3.4 MediWound
14.3.5 Virchow
